Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 424

1.

Effect of Underlying Renal Disease on Nutritional and Metabolic Profile of Older Adults with Reduced Renal Function.

Lai S, Amabile MI, Altieri S, Mastroluca D, Lai C, Aceto P, Crudo M, D'Angelo AR, Muscaritoli M, Molfino A.

Front Nutr. 2017 Mar 17;4:4. doi: 10.3389/fnut.2017.00004. eCollection 2017.

2.

The Effects of Long-Term Chaetomellic Acid A Administration on Renal Function and Oxidative Stress in a Rat Model of Renal Mass Reduction.

Nogueira A, Peixoto F, Oliveira MM, Pires CA, Colaço B, Oliveira PA, Pires MJ.

Biomed Res Int. 2017;2017:5125980. doi: 10.1155/2017/5125980. Epub 2017 Feb 23.

3.

Renal functional outcomes after surgery for renal cortical tumors.

Lascano D, Finkelstein JB, DeCastro GJ, McKiernan JM.

J Kidney Cancer VHL. 2015 Apr 4;2(2):45-54. doi: 10.15586/jkcvhl.2015.26. eCollection 2015.

4.

Features of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic Whites.

Venepalli NK, Modayil MV, Berg SA, Nair TD, Parepally M, Rajaram P, Gaba RC, Bui JT, Huang Y, Cotler SJ.

World J Hepatol. 2017 Mar 8;9(7):391-400. doi: 10.4254/wjh.v9.i7.391.

5.

Relationship between disease stage and renal function in bisphosphonate-related osteonecrosis of the jaw.

Kim YH, Park HK, Choi NR, Kim SW, Kim GC, Hwang DS, Kim YD, Shin SH, Kim UK.

J Korean Assoc Oral Maxillofac Surg. 2017 Feb;43(1):16-22. doi: 10.5125/jkaoms.2017.43.1.16. Epub 2017 Feb 20.

6.

The Green Tea Polyphenol(-)-epigallocatechin-3-gallate and its beneficial roles in chronic kidney disease.

Bao H, Peng A.

J Transl Int Med. 2016 Sep 1;4(3):99-103. doi: 10.1515/jtim-2016-0031. Epub 2016 Sep 23. Review.

7.

Estimation of chronic kidney disease incidence from prevalence and mortality data in American Indians with type 2 diabetes.

Vijayakumar P, Hoyer A, Nelson RG, Brinks R, Pavkov ME.

PLoS One. 2017 Feb 6;12(2):e0171027. doi: 10.1371/journal.pone.0171027. eCollection 2017.

8.

Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKD.

Surana S, Kumar N, Vasudeva A, Shaikh G, Jhaveri KD, Shah H, Malieckal D, Fogel J, Sidhu G, Rubinstein S.

BMC Nephrol. 2017 Jan 17;18(1):26. doi: 10.1186/s12882-017-0443-7.

9.

Chronic kidney disease in Polish elderly population aged 75+: results of the WOBASZ Senior Survey.

Zdrojewski Ł, Król E, Rutkowski B, Piotrowski W, Pająk A, Drygas W, Zdrojewski T.

Int Urol Nephrol. 2017 Apr;49(4):669-676. doi: 10.1007/s11255-016-1477-7. Epub 2016 Dec 17.

10.

Neurological, psychological, and cognitive disorders in patients with chronic kidney disease on conservative and replacement therapy.

Lai S, Mecarelli O, Pulitano P, Romanello R, Davi L, Zarabla A, Mariotti A, Carta M, Tasso G, Poli L, Mitterhofer AP, Testorio M, Frassetti N, Aceto P, Galani A, Lai C.

Medicine (Baltimore). 2016 Nov;95(48):e5191.

11.

Exploring the molecular basis of age-related disease comorbidities using a multi-omics graphical model.

Zierer J, Pallister T, Tsai PC, Krumsiek J, Bell JT, Lauc G, Spector TD, Menni C, Kastenmüller G.

Sci Rep. 2016 Nov 25;6:37646. doi: 10.1038/srep37646.

12.

Comparison of the Renoprotective Effect of Febuxostat for the Treatment of Hyperuricemia between Patients with and without Type 2 Diabetes Mellitus: A Retrospective Observational Study.

Ito H, Antoku S, Abe M, Omoto T, Shinozaki M, Nishio S, Mifune M, Togane M, Nakata M, Yamashita T.

Intern Med. 2016;55(22):3247-3256. Epub 2016 Nov 15.

13.

Chronic kidney disease: identification and management in primary care.

Fraser SD, Blakeman T.

Pragmat Obs Res. 2016 Aug 17;7:21-32. eCollection 2016. Review.

14.

A computational model for simulating solute transport and oxygen consumption along the nephrons.

Layton AT, Vallon V, Edwards A.

Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1378-F1390. doi: 10.1152/ajprenal.00293.2016. Epub 2016 Oct 5.

PMID:
27707705
15.

1. Pathophysiology and Classification of Kidney Diseases.

Matovinović MS.

EJIFCC. 2009 Apr 20;20(1):2-11. eCollection 2009 Apr. No abstract available.

16.

Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis.

Currie G, Taylor AH, Fujita T, Ohtsu H, Lindhardt M, Rossing P, Boesby L, Edwards NC, Ferro CJ, Townend JN, van den Meiracker AH, Saklayen MG, Oveisi S, Jardine AG, Delles C, Preiss DJ, Mark PB.

BMC Nephrol. 2016 Sep 8;17(1):127. doi: 10.1186/s12882-016-0337-0.

17.

Plasma brain natriuretic peptide level in older outpatients with heart failure is associated with physical frailty, especially with the slowness domain.

Nishiguchi S, Nozaki Y, Yamaji M, Oya K, Hikita Y, Aoyama T, Mabuchi H.

J Geriatr Cardiol. 2016 Jul;13(7):608-14. doi: 10.11909/j.issn.1671-5411.2016.07.014.

18.

Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands.

Miquel-Cases A, Steuten LM, Rigter LS, van Harten WH.

BMC Cancer. 2016 Sep 5;16:712. doi: 10.1186/s12885-016-2653-y.

19.

Chronic kidney disease in children.

Becherucci F, Roperto RM, Materassi M, Romagnani P.

Clin Kidney J. 2016 Aug;9(4):583-91. doi: 10.1093/ckj/sfw047. Epub 2016 Jun 5.

20.

The Non-Dialysis Chronic Renal Insufficiency study (ND-CRIS): an open prospective hospital-based cohort study in France.

Massol J, Janin G, Bachot C, Gousset C, Sainte-Claire Deville G, Chalopin JM.

BMC Nephrol. 2016 Jul 22;17(1):92. doi: 10.1186/s12882-016-0307-6.

Supplemental Content

Support Center